The future of the biochip market looks promising with opportunities in the hospitals, diagnostics centers, academic and research institutes, biotechnology and pharmaceutical industries. The global biochip market is expected to grow with a CAGR of 18% from 2019 to 2024. The major growth drivers for this market are increasing adoption of personalized medicine, increase in prevalence of cancer, immunological disorders, viral infections, geriatric population, and growing applications of biochip.
A report of more than 150-pages is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the biochip market, then read this report.
The study includes the biochip market size and forecast for the global biochip market through 2024, segmented by chip type, fabrication technology, application, material, end use, and region as follows:
By Chip type [$M shipment analysis for 2013-2024]:
By Fabrication Technology [$M shipment analysis for 2013-2024]:
By Application [$M shipment analysis for 2013-2024]:
By Material [$M shipment analysis for 2013-2024]:
By End Use [$M shipment analysis for 2013-2024]:
By Region [$M shipment analysis for 2013-2024]:
Some of the biochips companies profiled in this report include Abbott Laboratories, Agilent Technologies, Perkinelmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher Scientific, and F. Hoffmann-La Roche.
Some of the features of 'Global Biochip market 2019-2024: Trends, Forecast, and Opportunity Analysis' include
This report answers the following 11 key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the global biochip market by chip type (DNA chips, lab-on-a-chips, protein chips and others), fabrication technology (microarrays and microfluidics), application(drug discovery and development, disease diagnostics, genomics, proteomics, agriculture and others), material (glass, polymers, silicon and others), end use (biotechnology and pharmaceutical industries, hospitals and diagnostics centers, academic and research institutes, and others), and region (North America, Europe, Asia-Pacific, Rest of the World (ROW))?
Q.2.Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the biochip market?
Q.5. What are the business risks and threats to the biochip market?
Q.6. What are emerging trends in this biochip market and the reasons behind them?
Q.7. What are some changing demands of customers in the biochip market?
Q.8. What are the new developments in the biochip market? Which companies are leading these developments?
Q.9. Who are the major players in this biochip market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this biochip area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in biochip market?
A report of more than 150-pages is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the biochip market, then read this report.
The study includes the biochip market size and forecast for the global biochip market through 2024, segmented by chip type, fabrication technology, application, material, end use, and region as follows:
By Chip type [$M shipment analysis for 2013-2024]:
- DNA Chips Market
- Lab-on-a-Chip Market
- Protein Chips Market
- Others
By Fabrication Technology [$M shipment analysis for 2013-2024]:
- Microarrays
- Microfluidics
By Application [$M shipment analysis for 2013-2024]:
- Drug Discovery and Development
- Disease Diagnostics
- Genomics
- Proteomics
- Agriculture
- Others
By Material [$M shipment analysis for 2013-2024]:
- Glass
- Polymers
- Silicon
- Others
By End Use [$M shipment analysis for 2013-2024]:
- Biotechnology and Pharmaceutical industries
- Hospitals and Diagnostics Centers
- Academic and Research Institutes
- Others
By Region [$M shipment analysis for 2013-2024]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- France
- Germany
- Spain
- Italy
- Asia-Pacific
- China
- India
- Japan
- Rest of the World(ROW)
- Brazil
Some of the biochips companies profiled in this report include Abbott Laboratories, Agilent Technologies, Perkinelmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher Scientific, and F. Hoffmann-La Roche.
Some of the features of 'Global Biochip market 2019-2024: Trends, Forecast, and Opportunity Analysis' include
- Market size estimates: Global biochips market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis: Global market size by various applications such as by chip type, fabrication technology, application, material, end use, and region.
- Regional analysis: Global biochips market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities: Analysis on growth opportunities in different applications and regions for biochips in the global biochip market.
- Strategic analysis: This includes M&A, new product development, and competitive landscape for, biochips in the global biochip market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the global biochip market by chip type (DNA chips, lab-on-a-chips, protein chips and others), fabrication technology (microarrays and microfluidics), application(drug discovery and development, disease diagnostics, genomics, proteomics, agriculture and others), material (glass, polymers, silicon and others), end use (biotechnology and pharmaceutical industries, hospitals and diagnostics centers, academic and research institutes, and others), and region (North America, Europe, Asia-Pacific, Rest of the World (ROW))?
Q.2.Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the biochip market?
Q.5. What are the business risks and threats to the biochip market?
Q.6. What are emerging trends in this biochip market and the reasons behind them?
Q.7. What are some changing demands of customers in the biochip market?
Q.8. What are the new developments in the biochip market? Which companies are leading these developments?
Q.9. Who are the major players in this biochip market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this biochip area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in biochip market?
Table of Contents
1. Executive Summary
*Full List of Figures and Tables Available on Enquiry. 2. Market Background and Classifications
3. Market Trends and Forecast Analysis from 2013 to 2024
4. Market Trends and Forecast Analysis by Region
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies
- Perkinelmer
- Fluidigm
- Illumina
- GE Healthcare
- Bio-Rad Laboratories
- Cepheid
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
